Evotec (OTCMKTS:EVTCY) Sets New 1-Year Low at $3.64

Evotec SE (OTCMKTS:EVTCYGet Free Report) shares reached a new 52-week low on Tuesday . The stock traded as low as $3.64 and last traded at $3.84, with a volume of 236874 shares traded. The stock had previously closed at $4.33.

Evotec Stock Down 3.3 %

The firm has a market cap of $977.45 million, a price-to-earnings ratio of 7.46 and a beta of 0.98. The business’s 50-day moving average is $4.73 and its 200-day moving average is $6.11. The company has a debt-to-equity ratio of 0.53, a quick ratio of 2.50 and a current ratio of 2.57.

About Evotec

(Get Free Report)

Evotec SE engages in the discovery and development of new drugs for pharmaceutical and biotechnology companies. It operates through the following segments: EVT Execute and EVT Innovate. The EVT Execute segment provides stand-alone or integrated drug discovery solutions for collaborators targets and programmers on a typical fee-for-service basis or through a variety of commercial structures, which may include performance-based components, such as milestones and royalties.

See Also

Receive News & Ratings for Evotec Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Evotec and related companies with MarketBeat.com's FREE daily email newsletter.